相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer
Michael Graham Espey et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Complementary and alternative medicine: use and disclosure in radiation oncology community practice
Sarah M. Rausch et al.
SUPPORTIVE CARE IN CANCER (2011)
Vitamin C: A Concentration-Function Approach Yields Pharmacology and Therapeutic Discoveries
Mark Levine et al.
ADVANCES IN NUTRITION (2011)
High dose of ascorbic acid induces cell death in mesothelioma cells
Yukitoshi Takemura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Low Ascorbate Levels Are Associated with Increased Hypoxia-Inducible Factor-1 Activity and an Aggressive Tumor Phenotype in Endometrial Cancer
Caroline Kuiper et al.
CANCER RESEARCH (2010)
H2O2-mediated Cytotoxicity of Pharmacologic Ascorbate Concentrations to Neuroblastoma Cells: Potential Role of Lactate and Ferritin
Beate Deubzer et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2010)
Mechanisms of Ascorbate-Induced Cytotoxicity in Pancreatic Cancer
Juan Du et al.
CLINICAL CANCER RESEARCH (2010)
Added Value of Baseline 18F-FDG Uptake in Serial 18F-FDG PET for Evaluation of Response of Solid Extracerebral Tumors to Systemic Cytotoxic Neoadjuvant Treatment: A Meta-Analysis
Henriette M. E. Quarles van Ufford et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Evaluation of quality-of-life measures for use in palliative care: a systematic review
Gwenda Albers et al.
PALLIATIVE MEDICINE (2010)
Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects
Julien Verrax et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Effect of Small Interference RNA Targeting HIF-1α Mediated by rAAV Combined l-Ascorbate on Pancreatic Tumors in Athymic Mice
Chuangui Chen et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
L. J. Hoffer et al.
ANNALS OF ONCOLOGY (2008)
Arsenic Trioxide with Ascorbic Acid and High-Dose Melphalan: Results of a Phase II Randomized Trial
Muzaffar H. Qazilbash et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs
Mark L. Heaney et al.
CANCER RESEARCH (2008)
Ascorbate sustains neutrophil NOS expression, catalysis, and oxidative burst
Madhumita Chatterjee et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity
Richard Sullivan et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice
Qi Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Prognostic factors for stage III epithelial ovarian cancer: A Gynecologic Oncology Group Study
William E. Winter et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo
Qi Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Modulation of hypoxia-inducible factor-1 alpha in cultured primary cells by intracellular ascorbate
Margret C. M. Vissers et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Changes of terminal cancer patients' health-related quality of life after high dose vitamin C administration
Chang Hwan Yeom et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2007)
Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1α gene
Xianrang Song et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Vitamins C and K3 sensitize human urothelial tumors to gemcitabine
Wassim Kassouf et al.
JOURNAL OF UROLOGY (2006)
Associations between catalase phenotype and genotype: Modification by epidemiologic factors
Jiyoung Ahn et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Intravenously administered vitamin C as cancer therapy: three cases
SJ Padayatty et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2006)
Reversing hypoxic cell chemoresistance in vitro using genetic and small molecule approaches targeting hypoxia inducible factor-1
LM Brown et al.
MOLECULAR PHARMACOLOGY (2006)
Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues
Q Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Ascorbate uptake and antioxidant function in peritoneal macrophages
JM May et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2005)
Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1
KJ Williams et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Transport and intracellular accumulation of vitamin C in endothelial cells: relevance to collagen synthesis
JM May et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2005)
Activated nuclear factor-kappa B and cytokine profiles in the esophagus parallel tumor regression following neoadjuvant chemoradiotherapy
MMM Abdel-Latif et al.
DISEASES OF THE ESOPHAGUS (2005)
Vitamin C pharmacokinetics: Implications for oral and intravenous use
SJ Padayatty et al.
ANNALS OF INTERNAL MEDICINE (2004)
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules
BJ Moeller et al.
CANCER CELL (2004)
The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer
JA Drisko et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2003)
Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells
JM Grad et al.
BLOOD (2001)
Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours
JJ Casciari et al.
BRITISH JOURNAL OF CANCER (2001)
Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing P53
VG Reddy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
分享论文
